Listed

IPG Photonics Corp: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 5, 2021 and accepted by EDGAR at May 5, 2021, 16:49 ET.

Share

Management's discussion and analysis

As filed, 40,882 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion in conjunction with our condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This discussion contains forward looking statements that are based on management's current expectations, estimates and projections about our business and operations. Our actual results may differ materially from those currently anticipated and expressed in such forward-looking statements. See "Cautionary Statement Regarding Forward-Looking Statements."

Overview

We develop, manufacture and sell high-performance fiber lasers, fiber amplifiers and diode lasers that are used for diverse applications, primarily in materials processing. We also manufacture and sell complementary products used with our lasers including optical delivery cables, fiber couplers, beam switches, optical processing heads, in-line sensors and chillers. In addition, we offer laser-based and non-laser based systems for certain markets and applications. Our portfolio of laser solutions are used in materials processing, communications, medical and advanced applications. We sell our products globally to original equipment manufacturers ("OEMs"), system integrators and end users. We market our products internationally, primarily through our direct sales force. Our major manufacturing facilities are located in the United States, Germany, Russia and Belarus. We have sales service offices and applications laboratories worldwide.

We are vertically integrated such that we design and manufacture most of the key components used in our finished products, from semiconductor diodes to optical fiber preforms, finished fiber lasers, amplifiers and complementary products. Our vertically integrated operations allow us to reduce manufacturing costs, control quality, rapidly develop and integrate advanced products and protect our proprietary technology.

Factors and Trends That Affect Our Operations and Financial Results

In reading our financial statements, you should be aware of the following factors and trends that our management believes are important in understanding our financial performance.

COVID-19 Update. Global demand trends have been impacted adversely by the ongoing COVID-19 pandemic and therefore remain uncertain at this time. Economic indicators continue to show improvement from the severe contraction experienced one year ago, which has led to an improvement in the recent demand environment in certain regions. It is difficult to predict whether the improvement in some macroeconomic indicators will be sustained or if it could change if there are additional restrictions imposed as a result of a resurgence in COVID-19 infections. This uncertainty continues to make forecasting our business challenging in the near to medium term.

Currently, our four major production facilities in the United States, Germany, Russia and Belarus remain open and are operating with enhanced employee safety and sanitization protocols that have not significantly impacted productivity and efficiency. We have vertically integrated manufacturing, and many of the components one facility supplies to another facility are single sourced internally and not available from third party suppliers, for example our semiconductor diodes manufactured in Oxford, Massachusetts. While we have attempted to build safety stock of critical components at our various locations, if government restrictions to address COVID-19 become more severe than we have experienced to date or if there was significant absenteeism as a result of COVID-19 or resurgence in the places where we operate, it could impact our internal supply chain. If our revenues are reduced for an extended period or if our production output falls because of government restrictions or absenteeism, we may be required to reduce payroll-related costs and other expenses in the future through layoffs, furloughs or reduced hours, even though we have not done so to date.

We have not experienced significant supply disruption from third party component suppliers however lead times have increased for certain electronic components in particular. We have also faced constraints related to logistics, including available air cargo space and higher freight rates during the pandemic. While the impact of these constraints has moderated, they could recur if there is a resurgence in the virus, and we may experience delays in the future if governments implement new restrictions. We believe we have the ability to meet the near-term demand for our products, but the situation is fluid and subject to change.

We continue to monitor the rapidly evolving conditions and circumstances as well as guidance from international and domestic authorities, including public health authorities, and we may need to take additional actions based on their recommendations. The measures implemented by various authorities related to the COVID-19 outbreak have caused us to change our business practices including those related to where employees work, the distance between employees in our facilities, limitations on in-person meetings between employees and with customers, suppliers, service providers, and stakeholders as well as restrictions on business travel to domestic and international locations or to attend trade shows, investor conferences and other events. To date, we have been able to accommodate these changes to our business operations and continue to meet customer demand. If guidelines from relevant authorities becomes more restrictive due to a resurgence of COVID-19 in a particular region, the effect on our operations could be more significant.

Net sales. Our net sales have historically fluctuated from quarter to quarter. The increase or decrease in sales from a prior quarter can be affected by the timing of orders received from customers, the shipment, installation and acceptance of products at our customers' facilities, the mix of OEM orders and one-time orders for products with large purchase prices, competitive pressures, acquisitions, economic and political conditions in a certain country or region and seasonal factors such as the purchasing patterns and levels of activity throughout the year in the regions where we operate. Net sales can be affected by the time taken to qualify our products for use in new applications in the end markets that we serve. Our sales cycle varies substantially, ranging from a period of a few weeks to as long as one year or more, but is typically several months. The adoption of our products by a new customer or qualification in a new application can lead to an increase in net sales for a period, which may then slow until we penetrate new markets or obtain new customers.

Our business depends substantially upon capital expenditures by end users, particularly by manufacturers using our products for materials processing, which includes general manufacturing, automotive, other transportation, aerospace, heavy industry, consumer, semiconductor and electronics. Approximately 92% of our revenues for the first quarter of 2021 and 90% of our revenues for the full 2020 fiscal year were from customers using our products for materials processing. Although applications within materials processing are broad, the capital equipment market in general is cyclical and historically has experienced sudden and severe downturns. For the foreseeable future, our operations will continue to depend upon capital expenditures by end users of materials processing equipment and will be subject to the broader fluctuations of capital equipment spending.

In recent years, our net sales have been negatively impacted by tariffs and trade policy. New tariffs and other changes in U.S. trade policy could trigger retaliatory actions by affected countries, and certain foreign governments.

We are also susceptible to global or regional disruptions such as political instability, geopolitical conflicts, acts of terrorism, significant fluctuations in currency values, natural disasters, macroeconomic concerns and particularly the impact of the COVID-19 outbreak that affect the level of capital expenditures or global commerce. With respect to the COVID-19 outbreak specifically, while our financial results for the three months ended March 31, 2021 improved as compared to quarterly results achieved during 2020, the possible effect over the longer term continues to remain uncertain and dependent on future developments that cannot be accurately predicted at this time, such as the severity and transmission rate of the coronavirus or new variants, the extent and effectiveness of containment actions taken, the approval, effectiveness, timing and widespread inoculation of the global population with new vaccines, and the impact of these and other factors on our customer base and general commercial activity.

The average selling prices of our products generally decrease as the products mature. These decreases result from factors such as increased competition, decreased manufacturing costs and increases in unit volumes. We may also reduce selling prices in order to penetrate new markets and applications. Furthermore, we may negotiate discounted selling prices from time to time with certain customers that place high unit-volume orders.

The secular shift to fiber laser technology in large materials processing applications, such as cutting applications, had a positive effect on our sales trends in the past such that our sales trends were often better than other capital equipment manufacturers in both positive and negative economic cycles. As the secular shift to fiber laser technology matures in such applications, our sales trends are more susceptible to economic cycles which affect other capital equipment manufacturers.

Gross margin. Our total gross margin in any period can be significantly affected by total net sales in any period, by competitive factors, by product mix, and by other factors such as changes in foreign exchange rates relative to the U.S. Dollar, some of which are not under our control. For instance,

  • As our products mature, we can experience additional competition which tends to decrease average selling prices and affects gross margin;
  • Our gross margin can be significantly affected by product mix. Within each of our product categories, the gross margin is generally higher for devices with greater average power. The higher power products often have better performance, more difficult specifications to attain and fewer competing products in the marketplace;
  • Higher power lasers also use a greater number of optical components, improving absorption of fixed overhead costs and enabling economies of scale in manufacturing;
  • The gross margin for certain specialty products may be higher because there are fewer or sometimes no equivalent competing products;
  • Customers that purchase devices in greater unit volumes generally are provided a lower price per device than customers that purchase fewer units. In general, lower selling prices to high unit volume customers reduce gross margin although this may be partially offset by improved absorption of fixed overhead costs associated with larger product volumes, which drive economies of scale in manufacturing; and finally,
  • Gross margin on systems and communication components can be lower than the gross margin for our laser and amplifier sources, depending on the configuration, volume and competitive forces, among other factors.

We expect that some new technologies, products and systems will have returns above our cost of capital but may have gross margins below our corporate average. If we are able to develop opportunities that are significant in size, competitively advantageous or leverage our existing technology base and leadership, our current gross margin levels may not be maintained. Instead, we aim to deliver industry-leading gross margin by growing sales, by taking market share in existing markets, or by developing new applications and markets we address, by reducing the cost of our products and by optimizing the efficiency of our manufacturing operations. For instance, despite the decreases in sales in 2020, manufacturing levels remained high and our facilities increased production as we manufactured more optical power products at lower average selling prices.

A high proportion of our costs is fixed so costs are generally difficult to adjust or may take time to adjust in response to changes in demand. In addition, our fixed costs increase as we expand our capacity. If we expand capacity faster than is required by sales growth, gross margins could be negatively affected. Gross margins generally decline if production volumes are lower as a result of a decrease in sales or a reduction in inventory because the absorption of fixed manufacturing costs will be reduced. Gross margins generally improve when the opposite occurs. If both sales and inventory decrease in the same period, the decline in gross margin may be greater if we cannot reduce fixed costs or choose not to reduce fixed costs to match the decrease in the level of production. If we experience a decline in sales that reduces absorption of our fixed costs, or if we have production issues, our gross margins will be negatively affected.

We also regularly review our inventory for items that are slow-moving, have been rendered obsolete or determined to be excess. Any provision for such slow-moving, obsolete or excess inventory affects our gross margins. For example, we recorded provisions for slow-moving, obsolete or excess inventory totaling $8.0 million and $8.5 million for the three months ended March 31, 2021 and 2020, respectively.

Selling and general and administrative expenses. In the past, we have invested in selling and general and administrative costs in order to support continued growth in the Company. As the secular shift to fiber laser technology matures, our sales growth becomes more susceptible to the cyclical trends typical of capital equipment manufacturers. Accordingly, our future management of and investments in selling and general and administrative expenses will also be influenced by these trends, although we may still invest in selling or general and administrative functions to support certain initiatives even in economic down cycles. Certain general and administrative expenses are not related to the level of sales and may vary quarter to quarter based primarily upon the level of acquisitions and litigation.

Research and development expenses. We plan to continue to invest in research and development to improve our existing components and products and develop new components, products, systems and applications technology. We believe that these investments will sustain our position as a leader in the fiber laser industry and will support development of new products that can address new markets and growth opportunities. The amount of research and development expense we incur may vary from period to period.

Goodwill and long-lived assets impairments. We review our intangible assets and property, plant and equipment for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill is required to be tested for impairment at least annually. Negative industry or economic trends, including reduced estimates of future cash flows, disruptions to our business, slower growth rates, lack of growth in our relevant business units or differences in the estimated product acceptance rates could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets.

Our valuation methodology for assessing impairment requires management to make significant judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance at many points during the analysis. Also, the process of evaluating the potential impairment of goodwill is subjective. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. If our analysis indicates potential impairment to goodwill in one or more of our reporting units, we may be required to record charges to earnings in our financial statements, which could negatively affect our results of operations.

As discussed above, we continue to monitor the effect of the COVID-19 pandemic on our business and the potential affect it may have on the recoverability of our long-lived assets. The future effects of COVID-19 remain uncertain. If the future effects of COVID-19 accumulate and become larger or if our ability to predict the impact becomes more certain, it may become a triggering event which would cause us to evaluate the carrying value of our amortizable long-lived assets or to evaluate the carrying value of goodwill prior to the annual assessment date. If our analysis indicates potential impairment to goodwill, amortizable intangibles or right-of-use assets in one or more of our reporting units, we may be required to record charges to earnings in our financial statements, which would negatively affect our results of operations.

Foreign exchange. Because we are a U.S.-based company doing business globally, we have both translational and transactional exposure to fluctuations in foreign currency exchange rates. Changes in the relative exchange rate between the U.S. dollar and the foreign currencies in which our subsidiaries operate directly affects our sales, costs and earnings. Differences in the relative exchange rates between where we sell our products and where we incur manufacturing and other operating costs (primarily in the U.S., Germany, Russia and Belarus) also affects our costs and earnings. Certain currencies experiencing significant exchange rate fluctuations like the Euro, the Russian Ruble, the Japanese Yen and Chinese Yuan have had and could have an additional significant impact on our sales, costs and earnings. The depreciation of the Euro and Russian Ruble, partially offset by the depreciation of the Chinese Yuan created a foreign exchange gain for the quarter ended March 31, 2021 because our European and Russian subsidiaries have certain net assets denominated in U.S. Dollars, and our Chinese subsidiary has certain net liabilities denominated in U.S. Dollars. Our ability to adjust the foreign currency selling prices of products in response to changes in exchange rates is limited and may not offset the impact of the changes in exchange rates on the translated value of sales or costs. In addition, if we increase the selling price of our products in local currencies, this could have a negative impact on the demand for our products.

Major customers. While we have historically depended on a few customers for a large percentage of our annual net sales, the composition of this group can change from year to year. Net sales derived from our five largest customers as a percentage of our net sales was 24% for the three months ended March 31, 2021 and 24%, 21% and 26% for the full years 2020, 2019 and 2018, respectively. One of our customers accounted for 22% and 21% of our net accounts receivable as of March 31, 2021 and December 31, 2020, respectively. We seek to add new customers and to expand our relationships with existing customers. We anticipate that the composition of our significant customers will continue to change. We generally do not enter into agreements with our customers obligating them to purchase a fixed number or large volume of our fiber lasers or amplifiers. If any of our significant customers substantially reduced their purchases from us, our results would be adversely affected.

Results of Operations for the Three Months Ended March 31, 2021 Compared to the Three Months Ended March 31, 2020

Net sales. Net sales increased by $96.4 million, or 38.7%, to $345.6 million for the three months ended March 31, 2021 from $249.2 million for the three months ended March 31, 2020.

The table below sets forth sales by application:

(In thousands, except for percentages)

Sales by Application Three Months Ended March 31, 2021 % of Total 2020 % of Total Change
Materials processing $317,241 91.8% $218,074 87.5% $99,167 45.5%
Other applications 28,344 8.2% 31,168 12.5% (2,824) (9.1)%
Total $345,585 100.0% $249,242 100.0% $96,343 38.7%

20

The table below sets forth sales by type of product and other revenue:

(In thousands, except for percentages)

Sales by Product Three Months Ended March 31, 2021 % of Total 2020 % of Total Change
High Power Continuous Wave ("CW") Lasers $170,482 49.3% $119,316 47.9% $51,166 42.9%
Medium Power CW Lasers 15,882 4.6% 11,253 4.5% 4,629 41.1%
Pulsed Lasers 55,395 16.0% 31,839 12.8% 23,556 74.0%
Quasi-Continuous Wave ("QCW") Lasers 13,666 4.0% 9,873 4.0% 3,793 38.4%
Laser and Non-Laser Systems 27,116 7.8% 18,634 7.5% 8,482 45.5%
Other Revenue including Amplifiers, Service, Parts, Accessories and Change in Deferred Revenue 63,044 18.3% 58,327 23.3% 4,717 8.1%
Total $345,585 100.0% $249,242 100.0% $96,343 38.7%

Materials processing

Sales for materials processing applications increased due to higher sales from high power lasers, pulsed lasers, laser and non-laser systems, medium power lasers, other laser products and service, and QCW lasers. Sales for material processing applications improved as markets recover from being negatively affected by the COVID-19 pandemic in early 2020.

  • The increase in high power laser sales related to metal cutting and welding applications. Within cutting applications, increased sales were attributable to a recovery in the global demand environment from the impacts of a global lockdown related to the COVID-19 pandemic, primarily in China; partially offset by a decline in average selling prices and increased competition. Part of the decline in average selling prices for high power lasers is due to the adoption of more compact or rack mounted "YLR" series lasers, which are displacing 1 to 3 kilowatt "YLS" series lasers, which are larger, more complex and more expensive. These more compact YLR lasers are less expensive to manufacture and are sold at prices lower than the YLS series lasers they are displacing. The increase in sales of high power lasers used in welding applications was driven by higher sales into general manufacturing industries.
  • Medium power sales increased due to increased demand in laser sintering for metal-based additive manufacturing.
  • Pulsed laser sales increased due to growth in sales of high power pulsed lasers used for battery processing applications including foil cutting, solar cell manufacturing, and marking and engraving applications.
  • QCW laser sales increased due to increased demand for fine processing and consumer electronics applications.
  • Laser and non-laser systems sales increased due to higher demand of laser systems for cutting and welding applications, partially offset by decreased demand of non-laser systems in the transportation and aerospace sectors.
  • Other Revenue for materials processing increased due to higher parts and service revenue.

Other applications

Sales from other applications decreased due to lower demand in lasers used for medical procedures, partially offset by increased demand in lasers used for instrument and directed energy applications.

Cost of sales and gross margin. Cost of sales increased by $35.2 million, or 24.0%, to $181.6 million for the three months ended March 31, 2021 from $146.4 million for the three months ended March 31, 2020. Our gross margin increased to 47.5% for the three months ended March 31, 2021 from 41.3% for the three months ended March 31, 2020. The increase in gross margin was driven mainly by an increase in absorption of manufacturing expenses as a percent of sales due to higher sales. Gross margin also benefitted from lower cost of products sold and a reduction in provisions for inventory reserves versus the year ago period.

Sales and marketing expense. Sales and marketing expense increased by $0.2 million, or 1.1%, to $18.9 million for the three months ended March 31, 2021 compared with $18.7 million for the three months ended March 31, 2020. This change was primarily a result of increases in personnel costs partially offset by decreases in trade fair and exhibits. As a percentage of sales, sales and marketing expense decreased to 5.5% for the three months ended March 31, 2021 from 7.5% for the three months ended March 31, 2020, mainly due to increased sales.

Research and development expense. Research and development expense increased by $1.5 million, or 4.7%, to $33.3 million for the three months ended March 31, 2021, compared to $31.8 million for the three months ended March 31, 2020. This change was primarily a result of increases in personnel costs. As a percentage of sales, research and development expense decreased to 9.6% for the three months ended March 31, 2021 from 12.8% for the three months ended March 31, 2020, mainly due to the increase in sales.

General and administrative expense. General and administrative expense increased by $3.0 million, or 11.1%, to $30.1 million for the three months ended March 31, 2021 from $27.1 million for the three months ended March 31, 2020. This change was primarily a result of increases in personnel costs, information systems and gifts and donations. As a percentage of sales, general and administrative expense decreased to 8.7% for the three months ended March 31, 2021 from 10.9% for the three months ended March 31, 2020, mainly due to the increase in sales.

Effect of exchange rates on net sales, gross profit and operating expenses. We estimate that, if exchange rates relative to the U.S. Dollar had been the same as one year ago, which were on average Euro 0.91, Russian Ruble 67, Japanese Yen 109 and Chinese Yuan 6.98, respectively, we would have expected net sales to be $16.9 million lower, gross profit to be $10.0 million lower and total operating expenses to be $0.6 million higher.

(Gain) loss on foreign exchange. We incurred a foreign exchange gain of $7.2 million for the three months ended March 31, 2021 as compared to a $19.6 million gain for the three months ended March 31, 2020. The foreign exchange gain for the three months ended March 31, 2021 was primarily attributable to the depreciation of the Euro and Russian Ruble, partially offset by a loss attributed to the depreciation of the Chinese Yuan as compared to the U.S. Dollar. The foreign exchange gain for the three months ended March 31, 2020 was primarily attributable to depreciation of the Russian Ruble and Euro, partially offset by a loss attributed to the depreciation of the Chinese Yuan as compared to the U.S. Dollar.

Interest (expense) income, net. Interest expense, net was $0.5 million for the three months ended March 31, 2021 compared to interest income, net of $3.1 million for the three months ended March 31, 2020. The change in interest (expense) income, net is due to a reduction in yields on cash equivalents and short term investments.

Provision for income taxes. Provision for income taxes was $20.4 million (23.0% of pre-tax income) for the three months ended March 31, 2021 compared to $11.3 million (23.5% of pre-tax income) for the three months ended March 31, 2020. The higher tax expense in 2021 is primarily due to an increase in income.

Net income attributable to IPG Photonics Corporation. Net income attributable to IPG Photonics Corporation increased by $31.7 million to $68.1 million for the three months ended March 31, 2021 compared to $36.4 million for the three months ended March 31, 2020. Net income attributable to IPG Photonics Corporation as a percentage of our net sales increased by 5.1 percentage points to 19.7% for the three months ended March 31, 2021 from 14.6% for the three months ended March 31, 2020 due to the factors described above.

Liquidity and Capital Resources

The following table presents our principal sources of liquidity:

(In thousands)

March 31, 2021 December 31, 2020
Cash and cash equivalents $896,741 $876,231
Short-term investments 548,196 514,835
Unused credit lines and overdraft facilities 129,792 132,048
Working capital (excluding cash, cash equivalents and short-term investments) 542,571 542,433

Short-term investments at March 31, 2021, consist of liquid investments including U.S. Treasury and agency obligations, corporate bonds, commercial paper and certificates of deposit with original maturities of greater than three months but less than one year. See Note 5, "Fair Value Measurements" in the notes to the condensed consolidated financial statements for further information about our short-term investments.

We believe that our existing cash and cash equivalents, short-term investments, our cash flows from operations and our existing lines of credit provide us with the financial flexibility to meet our liquidity and capital needs. We expect to continue investments in capital expenditures, to assess acquisition opportunities and to repurchase shares of our stock in accordance with our repurchase program. The extent and timing of such expenditures may vary from period to period. Our future long-term capital requirements will depend on many factors including our level of sales, the impact of the economic environment on our growth including any ongoing impact of the COVID-19 pandemic on certain global or regional economies, global or regional recessions, the timing and extent of spending to support development efforts, expansion of global sales and marketing activities, government regulation including trade sanctions, the timing and introductions of new products, the need to ensure access to adequate manufacturing capacity and the continuing market acceptance of our products.

The following table details our line-of-credit facilities and long-term notes as of March 31, 2021:

Description Total Facility/ Note Interest Rate Maturity Security
U.S. Revolving Line of Credit (1) $75.0 million LIBOR plus 0.80% to 1.20%, depending on our performance April 2025 Unsecured
Euro Credit Facility (Germany) (2) Euro 50.0 million ($58.6 million) Euribor plus 0.75% or EONIA plus 1.00% July 2023 Unsecured, guaranteed by parent company and German subsidiary
Other Euro Facility (3) Euro 2.0 million ($2.3 million) Euribor plus 0.98% to 2.02% June 2021 Common pool of assets of Italian subsidiary
Long-term Secured Note (4) $18.9 million Fixed at 2.74% July 2022 Secured by the corporate aircraft
Long-term Unsecured Note (5) $18.1 million 1.20% above LIBOR, fixed using an interest rate swap at 2.85% per annum May 2023 Unsecured

(1) This facility is available to certain foreign subsidiaries in their respective local currencies. At March 31, 2021, there were no amounts drawn on this line; however, there were $3.3 million of guarantees issued against the line which reduces total availability.

(2) This facility is also available to certain foreign subsidiaries in their respective local currencies. At March 31, 2021, there were no drawings on this facility; however, there were $2.9 million of guarantees issued against the line which reduces total availability.

(3) At March 31, 2021, there were no drawings. This facility renews annually.

(4) At maturity, the outstanding note balance will be $15.4 million.

(5) At maturity, the outstanding note balance will be $15.4 million.

Our largest committed credit lines are with Bank of America N.A. and Deutsche Bank AG in the amounts of $75.0 million and $58.6 million (or 50.0 million Euro as described above), respectively, and neither of them is syndicated. We plan to seek amendments of our credit agreements and notes to modify LIBOR and Euribor reference rates as these rates are phased out as borrowing rates.

We are required to meet certain financial covenants associated with our U.S. revolving line of credit and long-term debt facility. These covenants, tested quarterly, include an interest coverage ratio and a funded debt to earnings before interest, taxes, depreciation and amortization ("EBITDA") ratio. The interest coverage covenant requires that we maintain a trailing twelve-month ratio of EBITDA to interest on all obligations that is at least 3.0:1.0. The funded debt to EBITDA covenant requires that the sum of all indebtedness for borrowed money on a consolidated basis be less than three times our trailing twelve months EBITDA. Funded debt is decreased by our cash and available marketable securities not classified as long-term investments in the U.S.A. in excess of $50 million up to a maximum of $500 million. We were in compliance with all such financial covenants as of and for the three months ended March 31, 2021.

The financial covenants in our loan documents may cause us to not make or to delay investments and actions that we might otherwise undertake because of limits on capital expenditures and amounts that we can borrow or lease. In the event that we do not comply with any one of these covenants, we would be in default under the loan agreement or loan agreements, which may result in acceleration of the debt, cross-defaults on other debt or a reduction in available liquidity, any of which could harm our results of operations and financial condition.

See Note 10, "Financing Arrangements" in the notes to the condensed consolidated financial statements for further information about our facilities and term debt.

The following table presents cash flow activities:

(In thousands)

Three Months Ended March 31, 2021 2020
Cash provided by operating activities $87,543 $56,781
Cash used in investing activities (60,694) (139,754)
Cash used in financing activities (1,637) (20,792)

Operating activities. Net cash provided by operating activities increased by $30.7 million to $87.5 million for the three months ended March 31, 2021 from $56.8 million for the three months ended March 31, 2020. In 2021, net sales and net income increased by 39% and 86%, respectively. As there were increases in net sales and net income, cash provided by net income after adding back non-cash charges increased. This increase has been partially offset by an increase in the amount invested in working capital. Our largest working capital items typically are inventory and accounts receivable. Items such as accounts payable to third parties, prepaid expenses and other current assets and accrued expenses and other liabilities are not as significant as our working capital investment in accounts receivable and inventory because of our vertically integrated structure. Accruals and payables for personnel costs including bonuses and income and other taxes payable are largely dependent on the timing of payments for those items. The increase in cash provided by operating activities in 2021 primarily resulted from an increase in cash provided by net income after adding back non-cash charges, an increase in cash provided by accounts payable, a decrease in cash used by prepaid expenses, and a decrease in cash used by income and other taxes payable; partially offset by, a decrease in cash provided by accounts receivable, an increase in cash used by accrued expenses, and an increase in cash used by inventory.

Investing activities. Net cash used in investing activities was $60.7 million for the three months ended March 31, 2021 as compared to cash used in investing activities of $139.8 million in 2020. The cash used in investing activities in 2021 related to $33.4 million of net purchases of short-term investments and $27.4 million of capital expenditures. The cash used in investing activities in 2020 related to $122.2 million of net purchases of short-term investments and $17.8 million of capital expenditures.

In 2021, we expect to incur between $150 million and $160 million in capital expenditures, excluding acquisitions. Capital expenditures include investments in property, facilities and equipment to add capacity worldwide to support anticipated revenue growth, increase vertical integration, increase redundant manufacturing capacity for critical components and enhance research and development capabilities. The timing and extent of any capital expenditures in and between periods can have a significant effect on our cash flow. If we obtain financing for certain projects, our cash expenditures would be reduced in the year of expenditure. Many of the capital expenditure projects that we undertake have long lead times and are difficult to cancel or defer to a later period.

Financing activities. Net cash used in financing activities was $1.6 million for the three months ended March 31, 2021 as compared to net cash used of $20.8 million in 2020. The cash used in financing activities in 2021 related to the purchase of treasury stock of $3.0 million, $2.6 million of payments of purchase price holdbacks from business combinations and $0.9 million of principal payments on our long-term borrowings; partially offset by, proceeds of $5.0 million from the exercise of stock options net of amounts disbursed in relation to shares withheld to cover employee income taxes due upon the vesting and release of restricted stock units. The cash used in financing activities in 2020 was primarily related to the purchase of treasury stock of $12.7 million, $5.5 million from the exercise of stock options net of amounts disbursed in relation to shares withheld to cover employee income taxes due upon the vesting and release of restricted stock units and $0.9 million of principal payments on our long-term borrowings.

Cautionary Statement Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and we intend that such forward-looking statements be subject to the safe harbors created thereby. For this purpose, any statements contained in this Quarterly Report on Form 10-Q except for historical information are forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements. In addition, any statements that refer to projections of our future financial performance, trends in our businesses, or other characterizations of future events or circumstances are forward-looking statements.

The forward-looking statements included herein are based on current expectations of our management based on available information and involve a number of risks and uncertainties, all of which are difficult or impossible to accurately predict and many of which are beyond our control. As such, our actual results may differ significantly from those expressed in any forward- looking statements. Factors that may cause or contribute to such differences include, but are not limited to, those discussed in more detail in Item 1, "Business" and Item 1A, "Risk Factors" of Part I of the Form 10-K filed with the SEC for the year ended December 31, 2020 (the "Annual Report"). Readers should carefully review these risks, as well as the additional risks described in other documents we file from time to time with the Securities and Exchange Commission. In light of the significant risks and uncertainties inherent in the forward-looking information included herein, the inclusion of such information should not be regarded as a representation by us or any other person that such results will be achieved, and readers are cautioned not to rely on such forward-looking information. We undertake no obligation to revise the forward-looking statements contained herein to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Recent Accounting Pronouncements

See Note 2 in the Notes to Condensed Consolidated Financial Statements for a full description of recent accounting pronouncements, including the respective dates of adoption or expected adoption and effects on our condensed consolidated financial statements contained in Item 1 of this Quarterly Report.

Market risk

As filed, 5,387 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are exposed to market risk in the ordinary course of business, which consists primarily of interest rate risk associated with our cash and cash equivalents and our debt and foreign exchange rate risk.

Interest rate risk. Certain interest rates are variable and fluctuate with current market conditions. Our investments have limited exposure to market risk. We maintain a portfolio of cash, cash equivalents and short-term investments consisting primarily of bank deposits, money market funds, certificates of deposit, commercial paper, corporate bonds and government and agency securities. None of these investments have a maturity date in excess of one year. Because of the short-term nature of these instruments, a sudden change in market interest rates would not be expected to have a material impact on our financial condition or results of operations.

We are also exposed to market risk as a result of increases or decreases in the amount of interest expense we must pay on our bank debt and borrowings on our bank credit facilities. Our interest obligations on our long-term debt are fixed either by the underlying agreement or by means of an interest rate swap agreement. Although our U.S. revolving line of credit and our Euro credit facility have variable rates, we do not believe that a 10% change in market interest rates would have a material impact on our financial position or results of operations.

Exchange rates. Due to our international operations, a significant portion of our net sales, cost of sales and operating expenses are denominated in currencies other than the U.S. Dollar, principally the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. As a result, our international operations give rise to transactional market risk associated with exchange rate movements of the U.S. Dollar, the Euro, the Russian Ruble, the Chinese Yuan and the Japanese Yen. The gain on foreign exchange transactions totaled $7.2 million for the three months ended March 31, 2021 compared to a gain of $19.6 million for the three months ended March 31, 2020. Management attempts to minimize these exposures by partially or fully off-setting foreign currency denominated assets and liabilities at our subsidiaries that operate in different functional currencies. The effectiveness of this strategy can be limited by the volume of underlying transactions at various subsidiaries and by our ability to accelerate or delay inter-company cash settlements. As a result, we are unable to create a perfect offset of the foreign currency denominated assets and liabilities. At March 31, 2021, our material foreign currency exposure is net U.S. Dollar denominated assets at subsidiaries where the Euro or the Russian Ruble is the functional currency and U.S. Dollar denominated liabilities where the Chinese Yuan is the functional currency. The U.S. Dollar denominated assets are comprised of cash, third party receivables and inter-company receivables. The U.S. Dollar denominated liabilities are comprised of inter-company payables. A 5% change in the relative exchange rate of the U.S. Dollar to the Euro as of March 31, 2021 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $6.8 million if the U.S. Dollar appreciated and a $7.1 million foreign exchange loss if the U.S. Dollar depreciated. A 5% change in the relative exchange rate of the U.S. Dollar to the Russian Ruble as of March 31, 2021 applied to the net U.S. Dollar asset balances, would result in a foreign exchange gain of $3.7 million if the U.S. Dollar appreciated and a $3.9 million foreign exchange loss if the U.S. Dollar depreciated. A 5% change in the relative exchange rate of the U.S. Dollar to the Chinese Yuan as of March 31, 2021 applied to the net U.S. Dollar liabilities balances, would result in a foreign exchange loss of $6.6 million if the U.S. Dollar appreciated and a $7.0 million foreign exchange gain if the U.S. Dollar depreciated. It is possible that the COVID-19 Pandemic may create additional volatility in exchange rates going forward.

In addition, we are exposed to foreign currency translation risk for those subsidiaries whose functional currency is not the U.S. Dollar as changes in the value of their functional currency relative to the U.S. Dollar can adversely affect the translated amounts of our revenue, expenses, net income, assets and liabilities. This can, in turn, affect the reported value and relative growth of sales and net income from one period to the next. In addition, changes in the translated value of assets and liabilities due to changes in functional currency exchange rates relative to the U.S. Dollar result in foreign currency translation adjustments that are a component of other comprehensive income or loss.

Foreign currency derivative instruments can also be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We have no foreign currency derivative instruments as of March 31, 2021. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange rate fluctuations may adversely affect our financial results in the future.

Controls and procedures

As filed, 1,190 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Under the supervision of our chief executive officer and our chief financial officer, our management has evaluated the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this Quarterly Report on Form 10-Q (the "Evaluation Date"). Based upon that evaluation, our chief executive officer and our chief financial officer have concluded that, as of the Evaluation Date, our disclosure controls and procedures are effective.

Changes in Internal Controls

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act) that occurred during the last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

Risk factors

As filed, 637 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the other information in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2020, which could materially and adversely affect our financial condition, results of operations or cash flows, or cause our actual results to differ materially from those projected in any forward-looking statements. We may also face other risks and uncertainties that are not presently known, are not currently believed to be material, or are not identified in our Annual Report because they are common to all businesses.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$345.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2021-01-01 to 2021-03-31$181.6mus-gaap:CostOfRevenue
Gross profit3 months2021-01-01 to 2021-03-31$164.0mus-gaap:GrossProfit
Research and development3 months2021-01-01 to 2021-03-31$33.3mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-01-01 to 2021-03-31$88.8mus-gaap:OperatingIncomeLoss
Income tax3 months2021-01-01 to 2021-03-31$20.4mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31$68.1mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-01-01 to 2021-03-31$1.26us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-01-01 to 2021-03-31$1.27us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-01-01 to 2021-03-3154,201,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2021-01-01 to 2021-03-31$87.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$27.4mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases3 months2021-01-01 to 2021-03-31$3.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2021-03-31$896.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$2.20bnus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$2.98bnus-gaap:Assets
Current liabilitiesAt period end2021-03-31$214.8mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$342.3mus-gaap:Liabilities
Long-term debtAt period end2021-03-31$33.2mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2021-03-31$3.8mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2021-03-31$2.64bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001111928-21-000101. Last ingested by Listed: Nov 4, 2026, 17:26 ET. Listed shows no prices and gives no investment advice.